News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
July, 2025
July 2025
M T W T F S S
 123456
78910111213
14151617181920
21222324252627
28293031  
Filippo Montemurro: Uncovering Actionable Targets in GATA3-Mutant HR+ Resistant Tumors
Collage photo of Filippo Montemurro and Arielle J. Medford
Jul 6, 2025, 15:32

Filippo Montemurro: Uncovering Actionable Targets in GATA3-Mutant HR+ Resistant Tumors

Filippo Montemurro, Senior Medical Director at Roche, shared a post on X about a paper by Arielle J. Medford et al. published in Breast Cancer Research and Treatment:

“Conoccurring mutations in GATA3 mutant tumors may reveal actionable targets in HR+ resistant tumors. Genomic and proteomic profiling of GATA3 mutant metastatic hormone receptor-positive breast cancer and impact on clinical outcomes – PubMed.”

Title: Genomic and proteomic profiling of GATA3 mutant metastatic hormone receptor-positive breast cancer and impact on clinical outcomes

Authors: Arielle J. Medford, Marko Velimirovic, Yifat Gefen, Andrzej Niemierko, Lorenzo Gerratana, Andrew A. Davis, Katherine Clifton, Jennifer Keenan, Emily Podany, Whitney L. Hensing, Carolina Reduzzi, Charles S. Dai, Lesli A. Kiedrowski, Laura M. Spring, Leif W. Ellisen, Robert C. Doebele, Massimo Cristofanilli, Gad Getz, Aditya Bardia

You can read the Full Article in Breast Cancer Research and Treatment.

Filippo Montemurro: Uncovering Actionable Targets in GATA3-Mutant HR+ Resistant Tumors

More posts featuring Filippo Montemurro.

Aditya Bardia Andrzej Niemierko Arielle J. Medford Breast Cancer Breast Cancer Research and Treatment cancer Filippo Montemurro Gad Getz GATA3 Laura M. Spring Leif W. Ellisen Lorenzo Gerratana Marko Velimirovic Massimo Cristofanilli OncoDaily Oncology Robert C. Doebele Yifat Gefen
Special Coverage
Insight
Jul 28, 2025, 10:17
Real-World Insights Into Pulmonary Sarcomatoid Carcinoma, Shared by Laura Alder and Tejas Patil
Blog
Jul 28, 2025, 10:00
Miriam Mutebi: What Does AI Have to Do with African Women Facing Breast Cancer?
Insight
Jul 28, 2025, 09:59
Dr. Daniel Heng – Breakthrough Research Award: Yvonne Awards 2025
Blog
Jul 28, 2025, 09:54
Scientific Progress Drives Development of Therapies Targeting Disease at the Cellular Source - Servier
Blog
Jul 28, 2025, 09:52
Thor Halfdanarson: Bassam Sonbol on Emerging Targets in Gastroesophageal Cancers at MD Education Meeting
Dialogues
Jul 28, 2025, 09:49
Empowering Oncologists: Evolving role of AI in Oncology
Dialogues
Jul 28, 2025, 09:47
How Can We Better Support Cancer Patients? Lidia Schapira Shares Insights | MASCC 2025
Science
Jul 28, 2025, 09:45
Yan Leyfman: When is Risk-Reducing Mastectomy (RRM) Cost-Effective?
Blog
Jul 28, 2025, 09:36
How Reirradiation is Becoming a Key Strategy in Recurrent Glioma Care - ESTRO
Science
Jul 28, 2025, 09:34
Myeloma Paper of the Day, July 28th, Suggested by Robert Orlowski
Blog
Jul 28, 2025, 09:27
Hannatu Ayuba: The Survivor Stories Inspire Action for Improvements and Changes in Policy
Blog
Jul 28, 2025, 09:13
Pim van der Harst: Shaping the Future of Cardio-Oncology Education